These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28044975)

  • 21. Aspects of splice site selection in constitutive and alternative pre-mRNA splicing.
    Inoue K; Ohno M; Shimura Y
    Gene Expr; 1995; 4(3):177-82. PubMed ID: 7734950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an intronic splicing regulatory element involved in auto-regulation of alternative splicing of SCL33 pre-mRNA.
    Thomas J; Palusa SG; Prasad KV; Ali GS; Surabhi GK; Ben-Hur A; Abdel-Ghany SE; Reddy AS
    Plant J; 2012 Dec; 72(6):935-46. PubMed ID: 22913769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
    Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
    Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
    Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
    RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly.
    Sharma S; Wongpalee SP; Vashisht A; Wohlschlegel JA; Black DL
    Genes Dev; 2014 Nov; 28(22):2518-31. PubMed ID: 25403181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing and bioinformatic analysis of human U12-type introns.
    Chang WC; Chen YC; Lee KM; Tarn WY
    Nucleic Acids Res; 2007; 35(6):1833-41. PubMed ID: 17332017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo commitment to splicing in yeast involves the nucleotide upstream from the branch site conserved sequence and the Mud2 protein.
    Rain JC; Legrain P
    EMBO J; 1997 Apr; 16(7):1759-71. PubMed ID: 9130720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMNrp is an essential pre-mRNA splicing factor required for the formation of the mature spliceosome.
    Meister G; Hannus S; Plöttner O; Baars T; Hartmann E; Fakan S; Laggerbauer B; Fischer U
    EMBO J; 2001 May; 20(9):2304-14. PubMed ID: 11331595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear cyclophilins affect spliceosome assembly and function in vitro.
    Adams BM; Coates MN; Jackson SR; Jurica MS; Davis TL
    Biochem J; 2015 Jul; 469(2):223-33. PubMed ID: 25967372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disturbances of alternative splicing in cancer].
    Wiszomirska H; Piekiełko-Witkowska A; Nauman A
    Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better.
    Nogués G; Kadener S; Cramer P; de la Mata M; Fededa JP; Blaustein M; Srebrow A; Kornblihtt AR
    IUBMB Life; 2003; 55(4-5):235-41. PubMed ID: 12880204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative splicing of pre-messenger RNAs in plants in the genomic era.
    Reddy AS
    Annu Rev Plant Biol; 2007; 58():267-94. PubMed ID: 17222076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alternative mRNA splicing, pathology and molecular therapeutics].
    Corcos L; Solier S
    Med Sci (Paris); 2005 Mar; 21(3):253-60. PubMed ID: 15745698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.
    Lopez AJ
    Annu Rev Genet; 1998; 32():279-305. PubMed ID: 9928482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
    Philippi S; Lorain S; Beley C; Peccate C; Précigout G; Spuler S; Garcia L
    Hum Mol Genet; 2015 Jul; 24(14):4049-60. PubMed ID: 25904108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Snu114p during pre-mRNA splicing.
    Frazer LN; Nancollis V; O'Keefe RT
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):551-3. PubMed ID: 18482006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.